Schedule 13G ownership disclosure
SILEXION THERAPEUTICS CORP
Ordinary Shares, par value $0.0009 per share · CUSIP: G1281K122
Event date: 2025-09-12
- Filing-level shares
- 131,250.00
- Percent of class
- 6.18%
- Lincoln Alternative Strategies LLC
Shares: 131,250.00 · Class: 6.18%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001493152-25-013429
- Form type
- SCHEDULE 13G
- Filer
- Lincoln Alternative Strategies LLC
- CIK
- CIK 2043812
- Filed
- Sep 15, 2025
- Reporting period
- Sep 12, 2025
- Description
- Schedule 13G beneficial ownership